Objective: To assess the effect of combined chemotherapy on levels of Anti-Mullerian Hormone (AMH). Metbod: This is a prospective cohort study on 12 non-gyne-cologic cancer women aged 20 - 40 years who received combined chemotherapy treatment. AMH levels and menstrual pattern before and after three months of chemotherapy were examined. The rela-tionships between age, chemotherapy regimens and …